The immune system plays a complex role in the recognition/prevention, early eradication as
well as progression of cancer. Recently, we have witnessed great momentum in the field of …

Since its inception in the 1940's, chemotherapy has remained the standard treatment for
many cancers. The morbidity and mortality associated with these drugs have triggered …

The crucial role of the immune system in the progression/regression of breast cancer (BC)
should always be taken into account. Various immunotherapy approaches have been …

Cancer cure with immunotherapy is an innovative step towards cancer treatment with better
survivability, but it is mostly dependent on the response of the patient's immune system to …

Breast cancer (BC) is one of the prevalent cancers among women. Generally, the treatment
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …

Background Advances have been made in the field of cancer immunotherapy in
understanding the role of the host immune response in affecting tumor progression and …

Triple‐negative breast cancer (TNBC) is characterized by the absence of estrogen receptor
(ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It …

Breast cancer is the principal cause of death in malig-nancy women, usually treated with the
combination of surgery, chemotherapy, radiotherapy and endocrinotherapy. With the de …

Breast cancer being the most malignant and lethal disease persistent among women
globally. Immunotherapy as a new treatment modality has emerged in understanding the …

Introduction: Breast cancer is the most common cancer as well as the first cause of death by
cancer in women worldwide. Although routine treatment improves the outcome of early …